Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2062-2070
Published online before print April 24, 2006, doi: 10.1161/CIRCULATIONAHA.105.577296
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
113/17/2062    most recent
CIRCULATIONAHA.105.577296v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lai, C.-Q.
Right arrow Articles by Ordovas, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lai, C.-Q.
Right arrow Articles by Ordovas, J. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Related Collections
Right arrow Risk Factors
Right arrow Other Treatment
Right arrow Other diagnostic testing
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease
Right arrow Lipid and lipoprotein metabolism

(Circulation. 2006;113:2062-2070.)
© 2006 American Heart Association, Inc.


Epidemiology

Dietary Intake of n-6 Fatty Acids Modulates Effect of Apolipoprotein A5 Gene on Plasma Fasting Triglycerides, Remnant Lipoprotein Concentrations, and Lipoprotein Particle Size

The Framingham Heart Study

Chao-Qiang Lai, PhD; Dolores Corella, PhD; Serkalem Demissie, PhD; L. Adrienne Cupples, PhD; Xian Adiconis, MSc; Yueping Zhu, MSc; Laurence D. Parnell, PhD; Katherine L. Tucker, PhD; Jose M. Ordovas, PhD

From the Nutrition and Genomics Laboratory (C-Q.L., D.C., X.A., Y.Z., L.D.P., J.M.O.) and the Dietary Assessment and Epidemiology Research Program (K.L.T.), JM-USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Mass; the Genetic and Molecular Epidemiology Unit (D.C.), School of Medicine, University of Valencia, Valencia, Spain; and the School of Public Health (S.D., L.A.C.), Boston University, Boston, Mass.

Correspondence to Dr C.-Q. Lai, Nutrition and Genomics Laboratory, JM-USDA-HNRCA, Tufts University, 711 Washington St, Boston, MA 02111. E-mail chao.lai{at}tufts.edu

Received July 20, 2005; revision received February 17, 2006; accepted February 23, 2006.

Background— Apolipoprotein A5 gene (APOA5) variation is associated with plasma triglycerides (TGs). However, little is known about whether dietary fat modulates this association.

Methods and Results— We investigated the interaction between APOA5 gene variation and dietary fat in determining plasma fasting TGs, remnant-like particle (RLP) concentrations, and lipoprotein particle size in 1001 men and 1147 women who were Framingham Heart Study participants. Polymorphisms –1131T>C and 56C>G, representing 2 independent haplotypes, were analyzed. Significant gene–diet interactions between the –1131T>C polymorphism and polyunsaturated fatty acid (PUFA) intake were found (P<0.001) in determining fasting TGs, RLP concentrations, and particle size, but these interactions were not found for the 56C>G polymorphism. The –1131C allele was associated with higher fasting TGs and RLP concentrations (P<0.01) in only the subjects consuming a high-PUFA diet (>6% of total energy). No heterogeneity by sex was found. These interactions showed a dose-response effect when PUFA intake was considered as a continuous variable (P<0.01). Similar interactions were found for the sizes of VLDL and LDL particles. Only in carriers of the –1131C allele did the size of these particles increase (VLDL) or decrease (LDL) as PUFA intake increased (P<0.01). We further analyzed the effects of n-6 and n-3 fatty acids and found that the PUFA–APOA5 interactions were specific for dietary n-6 fatty acids.

Conclusions— Higher n-6 (but not n-3) PUFA intake increased fasting TGs, RLP concentrations, and VLDL size and decreased LDL size in APOA5 –1131C carriers, suggesting that n-6 PUFA–rich diets are related to a more atherogenic lipid profile in these subjects.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
J. Nutr.Home page
J. Mattei, S. Demissie, K. L. Tucker, and J. M. Ordovas
Apolipoprotein A5 Polymorphisms Interact with Total Dietary Fat Intake in Association with Markers of Metabolic Syndrome in Puerto Rican Older Adults
J. Nutr., December 1, 2009; 139(12): 2301 - 2308.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Junyent, D. K. Arnett, M. Y. Tsai, E. K. Kabagambe, R. J. Straka, M. Province, P. An, C.-Q. Lai, L. D. Parnell, J. Shen, et al.
Genetic Variants at the PDZ-Interacting Domain of the Scavenger Receptor Class B Type I Interact with Diet to Influence the Risk of Metabolic Syndrome in Obese Men and Women
J. Nutr., May 1, 2009; 139(5): 842 - 848.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Warodomwichit, D. K. Arnett, E. K. Kabagambe, M. Y. Tsai, J. E. Hixson, R. J. Straka, M. Province, P. An, C.-Q. Lai, I. Borecki, et al.
Polyunsaturated Fatty Acids Modulate the Effect of TCF7L2 Gene Variants on Postprandial Lipemia
J. Nutr., March 1, 2009; 139(3): 439 - 446.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
I. Sundl, M. Guardiola, G. Khoschsorur, R. Sola, J. C. Vallve, G. Godas, L. Masana, M. Maritschnegg, A. Meinitzer, N. Cardinault, et al.
Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene 1131T>C variant and associations with plasma lipids and lipid peroxidation
J. Lipid Res., November 1, 2007; 48(11): 2506 - 2513.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
X.-Y. Zheng and L. Liu
Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase
J. Lipid Res., August 1, 2007; 48(8): 1673 - 1680.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C.-Q. Lai, D. K. Arnett, D. Corella, R. J. Straka, M. Y. Tsai, J. M. Peacock, X. Adiconis, L. D. Parnell, J. E. Hixson, M. A. Province, et al.
Fenofibrate Effect on Triglyceride and Postprandial Response of Apolipoprotein A5 Variants: The GOLDN Study
Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1417 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. M Zivkovic and J B. German
Individual variation in the metabolic syndrome: a new perspective on the debate
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 240 - 241.
[Full Text] [PDF]